2008 Hope Now Award

Dr. Haura is studying how mutated proteins in lung cells cause cancer. He is developing new drugs that will kill cancer cells by specifically blocking the function of these abnormal proteins.

In particular, his work continues to focus on tyrosine kinase signaling pathways in lung cancer. The main focus is on STAT signaling pathways as well as SRC pathways, and preclinical and clinical studies are underway to better understand how inhibitors of these pathways may kill lung cancer cells. Finally, he and his team are invested in applying systems biology to understanding cancer signaling networks and how drugs impact these networks.